Senior Researcher

Michael holds a BSc (Hons) in Physiological Sciences and an MSc in Translational Cardiovascular Medicine from the University of Bristol, as well as a PgCert in Medical Toxicology from Cardiff University. Since 2020, he has held the role of Honorary Lecturer at Cardiff University, teaching on the Medical Toxicology MSc and the Medical Device Evaluation module within the Medical Engineering BEng.

At CEDAR, Michael focuses on the generation of real-world evidence to support healthcare adoption. As the public involvement lead, he specialises in patient-centered healthcare evaluations, qualitative research, and evidence synthesis, leading HTA projects within the NICE Healthtech Programme, as well as evaluating NHS Wales services in the areas of cancer, rare diseases, and medical devices.

Prior to CEDAR, Michael gained extensive clinical and diagnostic experience across general practice, secondary care, and laboratory medicine. Working as a Specialist in Poisons Information for the UK Health Security Agency (UKHSA), he advised clinicians nationwide on the management of complex poisoning cases and collaborated with the World Health Organisation (WHO) and Public Health England (PHE) on global public health initiatives. Michael also possesses strong expertise in the quality assurance of medical devices, having previously developed an ISO-accredited Faecal Immunochemical Testing (FIT) scheme for detecting gastrointestinal bleeding in colorectal cancer for the Wales External Quality Assessment Scheme (WEQAS).

For a full list of Michael's publications, please visit his ORCID profile.